First UF Health patient receives specialized treatment for advanced colorectal cancer
UF Health has successfully performed the first hepatic artery infusion, or HAI, pump procedure.
UF Health has successfully performed the first hepatic artery infusion, or HAI, pump procedure.
The first robotic-assisted nipple-sparing mastectomies have been successfully performed at UF Health by Lisa Spiguel, M.D.
Cancer patients who could benefit from participating in clinical trials may never hear about such opportunities. To overcome this silence, researchers are creating a new chapter for a training program that teaches physicians how to communicate with cancer patients about the value of controlled cancer studies.
Drs. Elias Sayour and Rowan Milner work with dog patients to develop treatments that may one day heal humans with brain and bone tumors.
A long-term study of nearly 900 childhood cancer survivors found that the heart-protective drug dexrazoxane significantly reduced chemotherapy-related heart damage for years after treatment.
Using an innovative technique, scientists discovered the first compound that effectively targets a protein that drives lung cancer.
Thomas George, M.D., FACP, FASCO, co-authored an AACI commentary on accelerating clinical trial activation.
The study will explore how breast stem cells contribute to the early stages of breast tumor development.
Ursolic acid appeared to generate its beneficial effects in skeletal muscle by acting directly on muscle cells, the study found.
UF Health Cancer Institute scientists are teaming up with experts at The Wertheim UF Scripps Institute to seek potential drug leads for many cancer types.